CD28 hinge used in chimeric antigen receptor (CAR) T-cells exhibits local structure and conformational exchange amidst global disorder.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
31 Aug 2024
Historique:
received: 21 06 2024
accepted: 21 08 2024
medline: 1 9 2024
pubmed: 1 9 2024
entrez: 31 8 2024
Statut: epublish

Résumé

T-cell therapies based on chimeric antigen receptor (CAR) targeting of a tumor-specific antigen offer hope for patients with relapsed or refractory cancers. CAR hinge and transmembrane regions link antigen recognition domains to intracellular signal transduction domains. Here, we apply biophysical methods to characterize the structure and dynamic properties of the CD28 CAR hinge (CD28H) used in an FDA-approved CD19 CAR for the treatment of B-lineage leukemia/lymphoma. By using nuclear Overhauser effect spectroscopy (NOESY), which detects even transiently occupied structural motifs, we observed otherwise elusive local structural elements amidst overall disorder in CD28H, including a conformational switch from a native β-strand to a 3

Identifiants

pubmed: 39217198
doi: 10.1038/s42003-024-06770-w
pii: 10.1038/s42003-024-06770-w
doi:

Substances chimiques

CD28 Antigens 0
Receptors, Chimeric Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1072

Subventions

Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : P41GM111135

Informations de copyright

© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Cappell, K. M. & Kochenderfer, J. N. Long-term outcomes following CAR T cell therapy: what we know so far. Nat. Rev. Clin. Oncol. 20, 359–371 (2023).
pubmed: 37055515 pmcid: 10100620 doi: 10.1038/s41571-023-00754-1
Fry, T. J. et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat. Med. 24, 20–28 (2018).
pubmed: 29155426 doi: 10.1038/nm.4441
Shah, N. N. et al. Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. Nat. Med. 26, 1569–1575 (2020).
pubmed: 33020647 doi: 10.1038/s41591-020-1081-3
Till, B. G. et al. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood, J. Am. Soc. Hematol. 119, 3940–3950 (2012).
Brudno, J. N. et al. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma. J. Clin. Oncol. 36, 2267–2280 (2018).
pubmed: 29812997 pmcid: 6067798 doi: 10.1200/JCO.2018.77.8084
Mikkilineni, L. & Kochenderfer, J. N. CAR T cell therapies for patients with multiple myeloma. Nat. Rev. Clin. Oncol. 18, 71–84 (2021).
pubmed: 32978608 doi: 10.1038/s41571-020-0427-6
Kheyrolahzadeh, K. et al. Theranostic chimeric antigen receptor (CAR)-T cells: Insight into recent trends and challenges in solid tumors. Life Sci. 328, 121917 (2023).
pubmed: 37422069 doi: 10.1016/j.lfs.2023.121917
Zhang, X., Zhu, L., Zhang, H., Chen, S. & Xiao, Y. CAR-T cell therapy in hematological malignancies: current opportunities and challenges. Front. Immunol. 13, 927153 (2022).
pubmed: 35757715 pmcid: 9226391 doi: 10.3389/fimmu.2022.927153
Spiegel, J. Y. et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat. Med. 27, 1419–1431 (2021).
pubmed: 34312556 pmcid: 8363505 doi: 10.1038/s41591-021-01436-0
Schneider, D. et al. Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models. Sci. Transl. Med. 13, eabc6401 (2021).
pubmed: 33762438 doi: 10.1126/scitranslmed.abc6401
Shalabi, H. et al. CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR. Blood J. Am. Soc. Hematol. 140, 451–463 (2022).
Long, A. H. et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med. 21, 581–590 (2015).
pubmed: 25939063 pmcid: 4458184 doi: 10.1038/nm.3838
Singh, N. et al. Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells. Nat. Med. 27, 842–850 (2021).
pubmed: 33888899 pmcid: 8451032 doi: 10.1038/s41591-021-01326-5
Fujiwara, K. et al. Hinge and transmembrane domains of chimeric antigen receptor regulate receptor expression and signaling threshold. Cells 9, 1182 (2020).
pubmed: 32397414 pmcid: 7291079 doi: 10.3390/cells9051182
Majzner, R. G. et al. Tuning the antigen density requirement for CAR T-cell activity. Cancer Discov. 10, 702–723 (2020).
pubmed: 32193224 pmcid: 7939454 doi: 10.1158/2159-8290.CD-19-0945
Muller, Y. D. et al. The CD28-Transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28. Front Immunol. 12, 639818 (2021).
pubmed: 33833759 pmcid: 8021955 doi: 10.3389/fimmu.2021.639818
Ramello, M. C. et al. An immunoproteomic approach to characterize the CAR interactome and signalosome. Sci. Signal 12, eaap9777 (2019).
pubmed: 30755478 pmcid: 6506216 doi: 10.1126/scisignal.aap9777
Chen, X. et al. The CD8α hinge is intrinsically disordered with a dynamic exchange that includes proline cis-trans isomerization. J. Magn. Reson 340, 107234 (2022).
pubmed: 35617919 pmcid: 9237829 doi: 10.1016/j.jmr.2022.107234
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
pubmed: 38718835 pmcid: 11168924 doi: 10.1038/s41586-024-07487-w
Evans, E. J. et al. Crystal structure of a soluble CD28-Fab complex. Nat. Immunol. 6, 271–279 (2005).
pubmed: 15696168 doi: 10.1038/ni1170
Wu, H., Cao, R., Wen, M., Xue, H. & OuYang, B. Structural characterization of a dimerization interface in the CD28 transmembrane domain. Structure 30, 803–812.e805 (2022).
pubmed: 35397202 doi: 10.1016/j.str.2022.03.004
Chen, X. et al. Prokaryotic ubiquitin-like protein pup is intrinsically disordered. J. Mol. Biol. 392, 208–217 (2009).
pubmed: 19607839 pmcid: 2734869 doi: 10.1016/j.jmb.2009.07.018
Buel, G. R. et al. Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10. Nat. Commun. 11, 1291 (2020).
pubmed: 32157086 pmcid: 7064531 doi: 10.1038/s41467-020-15073-7
Nowicka, U. et al. Mycobacterium tuberculosis copper-regulated protein SocB is an intrinsically disordered protein that folds upon interaction with a synthetic phospholipid bilayer. Proteins 84, 193–200 (2016).
pubmed: 26650755 doi: 10.1002/prot.24970
Kanelis, V. et al. Sequential assignment of proline-rich regions in proteins: application to modular binding domain complexes. J. Biomol. NMR 16, 253–259 (2000).
pubmed: 10805132 doi: 10.1023/A:1008355012528
Haar, W., Fermandjian, S., Vicar, J., Blaha, K. & Fromageot, P. 13C-nuclear magnetic resonance study of [85% 13C-enriched proline]thyrotropin releasing factor: 13C-13C vicinal coupling constants and conformation of the proline residue. Proc. Natl Acad. Sci. USA 72, 4948–4952 (1975).
pubmed: 813218 pmcid: 388851 doi: 10.1073/pnas.72.12.4948
Schubert, M., Labudde, D., Oschkinat, H. & Schmieder, P. A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics. J. Biomol. NMR 24, 149–154 (2002).
pubmed: 12495031 doi: 10.1023/A:1020997118364
Bermel, W. et al. Complete assignment of heteronuclear protein resonances by protonless NMR spectroscopy. Angew. Chem. Int. Ed. Engl. 44, 3089–3092 (2005).
pubmed: 15832397 doi: 10.1002/anie.200461794
Grathwohl, C. & Wüthrich, K. NMR studies of the rates of proline cis–trans isomerization in oligopeptides. Biopolym. Orig. Res. Biomol. 20, 2623–2633 (1981).
Walters, K. J., Matsuo, H. & Wagner, G. A simple method to distinguish intermonomer nuclear Overhauser effects in homodimeric proteins with C 2 symmetry. J. Am. Chem. Soc. 119, 5958–5959 (1997).
doi: 10.1021/ja963309k
Miles, A. J., Ramalli, S. G. & Wallace, B. A. DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data. Protein Sci. 31, 37–46 (2022).
pubmed: 34216059 doi: 10.1002/pro.4153
Schwieters, C. D., Kuszewski, J. J., Tjandra, N. & Clore, G. M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson 160, 65–73 (2003).
pubmed: 12565051 doi: 10.1016/S1090-7807(02)00014-9
Cordier, F., Nisius, L., Dingley, A. J. & Grzesiek, S. Direct detection of N-H[…]O=C hydrogen bonds in biomolecules by NMR spectroscopy. Nat. Protoc. 3, 235–241 (2008).
pubmed: 18274525 doi: 10.1038/nprot.2007.498
Cordier, F. & Grzesiek, S. Direct observation of hydrogen bonds in proteins by interresidue 3hJNC‘ scalar couplings. J. Am. Chem. Soc. 121, 1601–1602 (1999).
doi: 10.1021/ja983945d
Kohn, J. E. et al. Random-coil behavior and the dimensions of chemically unfolded proteins. Proc. Natl Acad. Sci. USA 101, 12491–12496 (2004).
pubmed: 15314214 pmcid: 515087 doi: 10.1073/pnas.0403643101
Wishart, D. S. & Sykes, B. D. The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J. Biomol. NMR 4, 171–180 (1994).
pubmed: 8019132 doi: 10.1007/BF00175245
Schwarzinger, S. et al. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123, 2970–2978 (2001).
pubmed: 11457007 doi: 10.1021/ja003760i
Schwalbe, M. et al. Structural impact of tau phosphorylation at threonine 231. Structure 23, 1448–1458 (2015).
pubmed: 26165593 doi: 10.1016/j.str.2015.06.002
Daly, N. L., Hoffmann, R., Otvos, L. & Craik, D. J. Role of phosphorylation in the conformation of T peptides implicated in Alzheimer’s disease. Biochemistry 39, 9039–9046 (2000).
pubmed: 10913317 doi: 10.1021/bi0004807
Teixeira, J. M. et al. IDPConformerGenerator: a flexible software suite for sampling the conformational space of disordered protein states. J. Phys. Chem. A 126, 5985–6003 (2022).
pubmed: 36030416 pmcid: 9465686 doi: 10.1021/acs.jpca.2c03726
Staller, M. V. et al. Directed mutational scanning reveals a balance between acidic and hydrophobic residues in strong human activation domains. Cell Syst. 13, 334–345.e335 (2022).
pubmed: 35120642 pmcid: 9241528 doi: 10.1016/j.cels.2022.01.002
Rogers, J. M. et al. Interplay between partner and ligand facilitates the folding and binding of an intrinsically disordered protein. Proc. Natl Acad. Sci. USA 111, 15420–15425 (2014).
pubmed: 25313042 pmcid: 4217413 doi: 10.1073/pnas.1409122111
Buel, G. R. & Walters, K. J. Can AlphaFold2 predict the impact of missense mutations on structure? Nat. Struct. Mol. Biol. 29, 1–2 (2022).
pubmed: 35046575 pmcid: 11218004 doi: 10.1038/s41594-021-00714-2
Seigner, J. et al. Solving the mystery of the FMC63-CD19 affinity. Sci. Rep. 13, 23024 (2023).
pubmed: 38155191 pmcid: 10754921 doi: 10.1038/s41598-023-48528-0
Mirazee, J. et al. 401 | Hinge length: A novel method of predicting cytotoxicity of CAR constructs against antigen-low leukemia. J. Immunother. Cancer 10, A423–A423 (2022).
Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
pubmed: 8520220 doi: 10.1007/BF00197809
Bartels, C., Xia, T. H., Billeter, M. & Güntert, P. & Wüthrich, K. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6, 1–10 (1995).
pubmed: 22911575 doi: 10.1007/BF00417486
Shen, Y., Delaglio, F., Cornilescu, G. & Bax, A. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR 44, 213–223 (2009).
pubmed: 19548092 pmcid: 2726990 doi: 10.1007/s10858-009-9333-z
Wuthrich, K., Billeter, M. & Braun, W. Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J. Mol. Biol. 169, 949–961 (1983).
pubmed: 6313936 doi: 10.1016/S0022-2836(83)80144-2
Holder, T. Radius of gyration, https://pymolwiki.org/index.php/Radius_of_gyration (2011).
Maciejewski, M. W. et al. NMRbox: A resource for biomolecular NMR computation. Biophys. J. 112, 1529–1534 (2017).
pubmed: 28445744 pmcid: 5406371 doi: 10.1016/j.bpj.2017.03.011
Sreerama, N. & Woody, R. W. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem 287, 252–260 (2000).
pubmed: 11112271 doi: 10.1006/abio.2000.4880

Auteurs

Varvara Folimonova (V)

Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

Xiang Chen (X)

Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

Hitendra Negi (H)

Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

Charles D Schwieters (CD)

Computational Biomolecular Magnetic Resonance Core, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Jess Li (J)

Macromolecular NMR Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

R Andrew Byrd (RA)

Macromolecular NMR Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

Naomi Taylor (N)

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Philippe Youkharibache (P)

Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Kylie J Walters (KJ)

Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA. kylie.walters@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH